tirzepatide heart failure Lilly's Reduced and Obesity Symptoms in Phase 3 Trial Tirzepatide Beneficial for Heart Failure

The rationale behind microdosing is to reduce the risk of common side effects such as nausea, vomiting, or gastrointestinal discomfort, which some patients experience during dose escalation

Scientists discover why ozempic may not work for some people A hidden genetic quirk may be making some people surprisingly resistant to the benefits of blockbuster GLP-1 diabetes drugs

Psychiatry 69, 10911099

According to NICE guidance (TA875), Wegovy is recommended for weight management only within specialist weight management services, and specifically for adults with: BMI 35 kg/m with at least one weight-related comorbidity Lower BMI thresholds (typically by 2.5 kg/m) may apply for people from some minority ethnic groups Treatment should be initiated only as part of a comprehensive weight management programme that includes dietary modification, increased physical activity, and behavioural support

Pain Foundation, produces online magazines with real stories and photographs of people coping with chronic pain